Protara Therapeutics, Inc.
TARA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001359931
No open-market purchases or sales by Protara Therapeutics, Inc. insiders were filed in the last 90 days; 119 institutions reported holding it in 13F filings for Q2 2026, worth $176.0M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Protara Therapeutics, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 34 | 38 | +4 |
| Shares | 4.57M | 10.4M | +5.88M (+128.6%) |
| Value | $18.3M | $22.2M | +$3.89M (+21.2%) |
New holders (11)
Institutions that held Protara Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ra Capital Management, L.P. | 1,900,000 | $3.95M | 0.05% |
| Armistice Capital, LLC | 520,000 | $1.08M | 0.03% |
| Velan Capital Investment Management LP | 480,000 | $998.4K | 0.57% |
| CVI Holdings, LLC | 302,746 | $629.7K | 0.54% |
| Woodline Partners LP | 100,001 | $208.0K | 0.00% |
| Marshall Wace, LLP | 77,351 | $160.9K | 0.00% |
| CIBC World Markets Inc. | 37,000 | $77.0K | 0.00% |
| Commonwealth Equity Services, LLC | 19,428 | $40.0K | 0.00% |
| Jane Street Group, LLC | 12,850 | $26.7K | 0.00% |
| Group One Trading, L.P. | 2,550 | $5.30K | 0.00% |
| Bank of America Corp | 149 | $310 | 0.00% |
Sold out (7)
Institutions that held Protara Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Simplex Trading, LLC | 17,850 | $71.0K |
| Two Sigma Securities, LLC | 17,393 | $69.7K |
| Dimensional Fund Advisors LP | 12,126 | $48.6K |
| Acadian Asset Management LLC | 6,314 | $25.0K |
| UBS Group AG | 3,725 | $14.9K |
| ADAR1 Capital Management, LLC | 2,000 | $8.02K |
| JPMorgan Chase & Co | 22 | $88 |